-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
On January 25, Huaxi Bio issued a notice that, in order to promote the development of the domestic sodium hyaluronic acid industry, and based on the approval of other countries and international organizations to use, Huaxi Bio applied to expand the use of sodium hyaluronic acid, recently approved by the National Health And Wellness Commission, and on January 7, 2021 issued a bulletin "on the physique entities (artificial cultivation) and other 1 The announcement of the five "three new foods" (Announcement No. 9 of 2020) announced the approval of the expansion of sodium hyalurinoate to dairy and dairy products, beverages, alcohol, cocoa products, chocolate and chocolate products (including cocoa butter chocolate and products) and general foods such as sweets and frozen beverages (not suitable for infants, pregnant women and lactating women).
data show that Huaxi Bio is the world's largest transparent sodium acetate research and development, production and sales enterprises, in 2019 the global market share reached 39%.
2004, Huaxi Bio began to promote the expansion of the scope of application of sodium hyalurino acid, the year declared sodium hyalurogenate as a new resource food, and was approved in 2008, but the scope of application is limited to health food raw materials.
It is worth mentioning that in June 2020, Huaxi Bio announced the acquisition of Dongying Forst Bioengineering Co., Ltd. for 290 million yuan, the company's main production and sales of sodium hyalurogenate raw materials, and food-grade-based, cosmetics-grade supplement, sodium hyalurogen in 2018 put into operation, with an annual production capacity of 100 tons.
for the acquisition of Forsyth, Huaxi Bio intends to enhance the company's overall production capacity of hyalurinoic acid, enrich the raw material sales area, to achieve industrial synergies in the sodium hyalurogenic acid business.
After the approval of new food raw materials for sodium hyalurino acid, Huaxi Bio said it will fully grasp the opportunity of the industry, mainly from two aspects to promote the development of the food business: food-grade sodium hyalurogenic acid raw materials business, with the company's many years of experience in overseas promotion of food-grade sodium hyalurino acid raw materials business, At the same time, relying on the company's scientific and technological advantages in basic research and applied basic research, to assist customers to develop more food added sodium hyalurino acid, functional food, the company will work with partners, the formation of its own team and other ways to develop related products, including oral liquid, florets, tablet candy and so on.